Based on its current operating plans, Prime Medicine (PRME) expects that its cash, cash equivalents and investments as of March 31, 2025 will be sufficient to fund its operating expenses and capital expenditure requirements into the first half of 2026.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PRME:
- Is PRME a Buy, Before Earnings?
- Biotech Alert: Searches spiking for these stocks today
- Cathie Wood Snags Robinhood Stock (HOOD) and GitLab (GTLB) as Markets Slide
- Biotech stocks slide as Marks resignation seen being negative for sector
- BMO says Peter Marks resignation ‘significant negative’ for biotech